Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine

Cell Death Differ. 2004 Jan;11(1):18-20. doi: 10.1038/sj.cdd.4401344.
No abstract available

Publication types

  • News
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Dementia / drug therapy*
  • Drug Delivery Systems / methods
  • Drug Design*
  • Humans
  • Memantine / pharmacology*
  • Memantine / therapeutic use
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*

Substances

  • Neuroprotective Agents
  • Receptors, N-Methyl-D-Aspartate
  • Memantine